[1]
М. И. Ликстанов, “EFFICACY AND SAFETY OF REGDANVIMAB THERAPY IN MODERATE COURSE OF COVID-19”, МК, vol. 22, no. 1, pp. 17–21, Feb. 2023, doi: 10.24412/2687-0053-2023-1-17-21.